Screener
Assembly Biosciences ASMB Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The source filing: Assembly Biosciences’s 10-Q, filed August 13, 2026.
- Filed
- Aug 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-349236
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Collaboration revenue from a related party | $13,374 | $9,626 | $21,587 | $19,045 |
| Operating expenses | ||||
| Research and development | 14,917 | 16,125 | 29,817 | 30,976 |
| General and administrative | 4,801 | 4,594 | 9,484 | 9,103 |
| Total operating expenses | 19,718 | 20,719 | 39,301 | 40,079 |
| Loss from operations | (6,344) | (11,093) | (17,714) | (21,034) |
| Other income | ||||
| Interest and other income, net | 2,487 | 895 | 4,778 | 2,018 |
Item 1. Financial Statements
FAQ
- What is Assembly Biosciences's total revenue?
- Assembly Biosciences (ASMB) reported total revenue of $13.37M in Q2 2026.
- How has Assembly Biosciences's total revenue changed year-over-year?
- Assembly Biosciences's total revenue increased by 38.9% year-over-year, from $9.63M to $13.37M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Assembly Biosciences's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude